Counteracting the effect of leukemia exosomes by antiangiogenic gold nanoparticles

References

• Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol. 2018;93(3):442–459. doi:10.1002/ajh.2501129411417
   PubMed Web of Science ®Google Scholar
• Kang ZJ, Liu YF, Xu LZ, et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016;35:48. doi:10.1186/s40880-016-0108-027233483
   PubMedGoogle Scholar
• Korkolopoulou P, Viniou N, Kavantzas N, et al. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia. 2003;17(1):89–97. doi:10.1038/sj.leu.240276912529665
   PubMedGoogle Scholar
• Deshantri AK, Varela Moreira A, Ecker V, et al. Nanomedicines for the treatment of hematological malignancies. J Control Release. 2018;287:194–215. doi:10.1016/j.jconrel.2018.08.03430165140
   PubMed Web of Science ®Google Scholar
• Rackov G, Garcia-Romero N, Esteban-Rubio S, Carrion-Navarro J, Belda-Iniesta C, Ayuso-Sacido A. Vesicle-mediated control of cell function: the role of extracellular matrix and microenvironment. Front Physiol. 2018;9:651. doi:10.3389/fphys.2018.0065129922170
   PubMed Web of Science ®Google Scholar
• Roma-Rodrigues C, Fernandes AR, Baptista PV. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed Res Int. 2014;2014:179486. doi:10.1155/2014/17948624963475
   PubMed Web of Science ®Google Scholar
• Sauter ER. Exosomes in blood and cancer. Transl Cancer Res. 2017;6(S8):S1316–S1320. doi:10.21037/tcr.2017.08.13
   Google Scholar
• Sauter ER. Exosomes in lymph and cancer. Transl Cancer Res. 2017;6(S8):S1311–S1315. doi:10.21037/tcr.2017.10.06
   Google Scholar
• Qiu JJ, Lin XJ, Tang XY, Zheng TT, Lin YY, Hua KQ. Exosomal metastasis‑associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer. Int J Biol Sci. 2018;14(14):1960–1973. doi:10.7150/ijbs.2804830585260
   PubMed Web of Science ®Google Scholar
• Aslan C, Maralbashi S, Salari F, et al. Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol. 2019;234:16885–16903. ahead of print. doi:10.1002/jcp.2837430793767
   PubMed Web of Science ®Google Scholar
• Taverna S, Flugy A, Saieva L, et al. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer. 2012;130(9):2033–2043. doi:10.1007/s10456-011-9241-121630268
   PubMed Web of Science ®Google Scholar
• Roma-Rodrigues C, Pereira F, Alves de Matos AP, Fernandes M, Baptista PV, Fernandes AR. Smuggling gold nanoparticles across cell types – a new role for exosomes in gene silencing. Nanomedicine. 2017;13(4):1389–1398. doi:10.1016/j.nano.2017.01.01328137659
   PubMedGoogle Scholar
• Taverna S, Amodeo V, Saieva L, et al. Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells. Mol Cancer. 2014;13:169. doi:10.1186/1476-4598-13-16925015105
   PubMed Web of Science ®Google Scholar
• Mineo M, Garfield SH, Taverna S, et al. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis. 2012;15(1):33–45. doi:10.1007/s10456-011-9241-122203239
   PubMedGoogle Scholar
• Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013;288(48):34343–34351. doi:10.1074/jbc.M113.48082224133215
   PubMed Web of Science ®Google Scholar
• Corrado C, Saieva L, Raimondo S, Santoro A, De Leo G, Alessandro R. Chronic myelogenous leukemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor. J Cell Mol Med. 2016;20(10):1829–1839. doi:10.1111/jcmm.1287327196940
   PubMedGoogle Scholar
• Raimondo S, Saieva L, Corrado C, et al. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun Signal. 2015;13:8. doi:10.1186/s12964-015-0086-x25644060
   PubMed Web of Science ®Google Scholar
• Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 2013;32(22):2747–2755. doi:10.1038/onc.2012.29522797057
   PubMed Web of Science ®Google Scholar
• Vinhas R, Mendes R, Fernandes AR, Baptista PV. Nanoparticles-emerging potential for managing leukemia and lymphoma. Front Bioeng Biotechnol. 2017;5:79. doi:10.3389/fbioe.2017.0007929326927
   PubMedGoogle Scholar
• Soni G, Yadav KS. Applications of nanoparticles in treatment and diagnosis of leukemia. Mater Sci Eng C Mater Biol Appl. 2015;47:156–164. doi:10.1016/j.msec.2014.10.04325492184
   PubMed Web of Science ®Google Scholar
• Roma-Rodrigues C, Heuer-Jungemann A, Fernandes AR, Kanaras AG, Baptista PV. Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo. Int J Nanomedicine. 2016;11:2633–2639. doi:10.2147/IJN.S10866127354794
   PubMed Web of Science ®Google Scholar
• Pedrosa P, Heuer-Jungemann A, Kanaras AG, Fernandes AR, Baptista PV. Potentiating angiogenesis arrest in vivo via laser irradiation of peptide functionalized gold nanoparticles. J Nanobiotechnology. 2017;15(1):85. doi:10.1186/s12951-017-0321-229162137
   PubMedGoogle Scholar
• Bartczak D, Sanchez-Elsner T, Louafi F, Millar TM, Kanaras AG. Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells. Small. 2011;7(3):388–394. doi:10.1002/smll.20100181621294268
   PubMedGoogle Scholar
• Bartczak D, Muskens OL, Sanchez-Elsner T, Kanaras AG, Millar TM. Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano. 2013;7(6):5628–5636. doi:10.1021/nn402111z23713973
   PubMed Web of Science ®Google Scholar
• Herzog B, Pellet-Manya C, Brittona G, Hartzoulakis B, Zachary IC. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell. 2011;22(15):2766–2776. doi:10.1091/mbc.E09-12-106121653826
   PubMed Web of Science ®Google Scholar
• Bartczak D, Sanchez-Elsner T, Louafi F, Millar TM, Kanaras AG. Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells. Small. 2010;7(3):388–394. doi:10.1002/smll.20100181621294268
   PubMedGoogle Scholar
• Bartczak D, Muskens OL, Nitti S, Millar TM, Kanaras AG. Nanoparticles for inhibition of in vitro tumour angiogenesis: synergistic actions of ligand function and laser irradiation. Biomater Sci. 2015;3(5):733–741. doi:10.1039/C5BM00053J26222592
   PubMed Web of Science ®Google Scholar
• Nowak-Sliwinska P, Segura T, Iruela-Arispe ML. The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis. 2014;17(4):779–804. doi:10.1007/s10456-014-9440-725138280
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55–75. doi:10.1039/DF9511100055
   Google Scholar
• Zhang Z, Neiva KG, Lingen MW, Ellis MW, Nör JE. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ. 2010;17(3):499–512. doi:10.1038/cdd.2009.15219834490
   PubMed Web of Science ®Google Scholar
• Sekiguchi K, Ito Y, Hattori K, et al. VEGF receptor 1-expressing macrophages recruited from bone marrow enhances angiogenesis in endometrial tissues. Sci Rep. 2019;9(1):7037. doi:10.1038/s41598-019-43185-831065021
   PubMedGoogle Scholar
• Chou MT, Wang J, Fujita DJ. Src Kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem. 2002;3:32. doi:10.1186/1471-2091-3-3212509223
   PubMed Web of Science ®Google Scholar
• Singh NK, Hansen DE 3rd, Kundumani-Sridharan V, Rao GN. Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCgamma-cPLA(2) activation and retinal neovascularization. Blood. 2013;121(10):1911–1923. doi:10.1182/blood-2012-03-41923423319572
   PubMedGoogle Scholar
• Nash GB, Buckley CD, Ed Rainger G. The local physicochemical environment conditions the proinflammatory response of endothelial cells and thus modulates leukocyte recruitment. FEBS Lett. 2004;569(1–3):13–17. doi:10.1016/j.febslet.2004.05.04015225601
   PubMedGoogle Scholar
• Ohyashiki JH, Umezu T, Ohyashiki K. Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia. Curr Opin Hematol. 2016;23(3):268–273. doi:10.1097/MOH.000000000000023526866730
   PubMedGoogle Scholar
• Anand S, Cheresh DA. MicroRNA-mediated regulation of the angiogenic switch. Curr Opin Hematol. 2011;18(3):171–176. doi:10.1097/MOH.0b013e328345a18021423013
   PubMedGoogle Scholar
• Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15(2):272–284. doi:10.1016/j.devcel.2008.07.00818694566
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15(2):261–271. doi:10.1016/j.devcel.2008.07.00218694565
   PubMed Web of Science ®Google Scholar